sr 95531 has been researched along with atipamezole in 1 studies
| Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (atipamezole) | Trials (atipamezole) | Recent Studies (post-2010) (atipamezole) |
|---|---|---|---|---|---|
| 610 | 0 | 209 | 530 | 64 | 143 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franks, NP; Guo, T; Lu, J; Maze, M; Nelson, LE; Saper, CB | 1 |
1 other study(ies) available for sr 95531 and atipamezole
| Article | Year |
|---|---|
The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Cell Count; Dexmedetomidine; Electroencephalography; Electromyography; Excitatory Amino Acid Agonists; GABA Antagonists; GABA-A Receptor Agonists; Gene Expression Regulation; Genes, fos; Hypnotics and Sedatives; Ibotenic Acid; Imidazoles; Immunohistochemistry; In Situ Hybridization; Mice; Mice, Inbred C57BL; Neural Pathways; Postural Balance; Pyridazines; Rats; Rats, Inbred F344; Receptors, Adrenergic, alpha-2; Sleep; Sleep, REM | 2003 |